Drug intelligence / Profile preview

glucosamine sulfate sodium chloride

Development stage
Unknown
Lead developer
Rotta Research
Modality
Small Molecules
Administration
Oral
01

Overview

Glucosamine sulfate sodium chloride is a stabilized salt form of the amino sugar glucosamine, which serves as a fundamental building block for the biochemical synthesis of glycosylated proteins and lipids. It is primarily utilized in the management of osteoarthritis, particularly of the knee, where it acts as a precursor for the synthesis of cartilage matrix components such as proteoglycans and glycosaminoglycans. Beyond its role as a substrate for cartilage repair, the drug exhibits anti-inflammatory properties by inhibiting the interleukin-1 beta (IL-1β) signaling pathway, thereby reducing the expression of inflammatory mediators like cyclooxygenase-2 (COX-2) and prostaglandin E2. While widely available as a dietary supplement in the United States, it is regulated as a prescription pharmaceutical in many European and Asian jurisdictions, with the crystalline formulation developed by Rottapharm being the most extensively studied clinical version.

Brand names
DonaViartril-SXicilOsaflexanFlexove
Other names
sodium glucosamineglucosamine sulfate sodiumcrystalline glucosamine sulfateglucosamine sulfate potassium chlorideglucosamine
02

Targets

ACAN (Aggrecan core protein)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)IL1B (Interleukin-1 beta)

Beyond the preview

Go deeper on glucosamine sulfate sodium chloride.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on glucosamine sulfate sodium chloride.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call